Chirality is becoming an essential issue in modern pharmaceutical research as regulatory agencies emphasize the safety and efficiency of enantiomers in drug development. The development of efficient and reliable chiral separation methods became a necessity in the last 30 years, and capillary electrophoresis (CE), due to its relatively low costs and “green” features, is attracting increased attention. Cyclodextrin (CD) and their derivatives are the most frequently used chiral selectors (CSs) in CE, however, the use of antibiotics as CSs represents an interesting alternative. Various classes of antibiotics (aminoglycosides, ansamycins, glycopeptides, lincosamides, macrolides, tetracyclines) have been used more or less successfully for the enantio-separation of pharmaceuticals. Antibiotics offer the possibility of a multitude of potential interactions (electrostatic, inclusion, hydrogen bonding, etc.) due to their chemical diversity, allowing the enantio-separation of analytes with a wide range of structural characteristics. This article aims to review the application of various classes of antibiotics in the CE enantio-separation of pharmaceuticals. Antibiotic physiochemical characteristics, variables impacting enantio-separation, advantages, and disadvantages when certain antibiotics are used as CSs in CE are also explored.

Lavender oil (LEO) is one of the most well-known essential oils worldwide which, besides its extensive application in aromatherapy, serves as raw material for various fields, including the food, cosmetic, and pharmaceutical industries. Accordingly, several global requirements were established to warrant its quality. Microencapsulation represents an emerging technology widely applied for the preservation of essential oils, simultaneously providing new ways of application. In the current study, lavender oil was obtained from the flowering tops of Lavandula angustifolia Mill. on a semi-industrial-scale steam distillation system. According to the GC-MS investigation, lavender oil obtained in the third year of cultivation met the European Pharmacopoeia standards for linalyl acetate and linalool contents ≈38% and ≈26%, respectively. Microcapsules (MCs) containing the so-obtained essential oil were successfully produced by complex coacervation technology between gum arabic (GA) and three different grades of type-A gelatin (GE). Optical microscopic investigations revealed a significant difference in particle size depending on the gelatin grade used. The variation observed for coacervates was well reflected on the scanning electron micrographs of the freeze-dried form. The highest encapsulation efficiency values were obtained by UV-VIS spectrophotometry for microcapsules produced using gelatin with the medium gel strength. FT-IR spectra confirmed the structural modifications attributed to microencapsulation. According to the GC-MS analysis of the freeze-dried form, the characteristic components of lavender oil were present in the composition of the encapsulated essential oil.

Yarrow (Achillea millefolium L., AM) is a widely used medicinal plant, with its essential oil highly valued in the cosmetic industry. In view of the numerous biological effects, however, microencapsulation, due to its ability to protect sensitive constituents, transform liquids into solid-state material, and provide modification of release kinetics, might open up new possibilities for the biomedical utilization of yarrow essential oil (AMO). In the current work, yarrow plantation was established by its propagation from spontaneous flora. Following the steam distillation of aerial parts, the chemical composition of the essential oil was determined by GC-MS analysis and compared with two commercial samples. This study concludes that Achillea millefolium L. from this region, given the environmental conditions, produces high-azulene-content essential oil. Furthermore, microencapsulation of AMO was successfully performed by complex coacervation into gelatin (GE) and gum arabic (GA) based core–shell microcapsules (MCs). According to the optical microscopic investigation, the particle sizes of the formed polynucleated microcapsules ranged from 14 to 132 µm, with an average of 47 µm. The assessment of morphology by SEM analysis of the freeze-dried form revealed a sponge-like character with embedded circular structures. The microencapsulation was confirmed by FT-IR spectroscopy and differential scanning calorimetry (DSC), while an encapsulation efficiency of 87.6% was determined by UV spectroscopy. GC-MS analysis revealed that microencapsulation preserves the key components of the essential oil. It was concluded that AMO can be effectively processed by complex coacervation followed by freeze-drying into solid-state material for new applications.

In recent years, the consumption of dietary supplements, particularly those incorporating plant-based ingredients, has increased greatly, driven by the perception of their natural origins and purported minimal health risks. However, one significant safety concern revolves around the adulteration of dietary supplements, wherein unscrupulous manufacturers may illegally incorporate pharmaceutical substances or their analogs into these products to achieve increased efficiency and bolster sales. This review assesses the role of capillary electrophoresis (CE) in ensuring the quality control of dietary supplement products over the past two decades. This study provides an overview of various applications of CE in analyzing dietary supplements, outlining the typical attributes of natural product analysis using CE. These analyses demonstrate the broad versatility of CE, exemplified by its diverse applications and detection modes. Moreover, the review highlights the growing prominence of CE as a separation technique in quality control, by comparison with more conventional methods like high-performance liquid chromatography (HPLC). Through this exploration, the review elucidates the pivotal role of CE in upholding the integrity and safety of dietary supplements, in connection with a landscape of evolving regulatory challenges and consumer demands.

Vildagliptin (VIL) is a dipeptidyl peptidase-4 inhibitor used in the treatment of type 2 diabetes mellitus; in therapy, it is available as the enantiomerically pure S-VIL, the other enantiomer R-VIL being considered as an enantiomeric impurity. A systematic screening of 16 cyclodextrin (CD) derivatives as chiral selectors was performed at three pH levels using phosphate (pH 2.5, pH 7.0) and acetate (pH 4.5) buffers. Method optimization employed an experimental design approach, systematically investigating the effect of buffer and CD concentration, buffer pH, capillary temperature, and applied voltage on the chiral resolution and analysis time. The method’s analytical performance was thoroughly assessed and subsequently employed for determining the enantiomeric purity of VIL in a pharmaceutical formulation. The properties of the inclusion complexes, such as stoichiometry and atomic level intermolecular host–guest interactions were studied by NMR measurements and molecular modeling. Native α-CD at acidic pH has demonstrated its exceptional suitability for the separation of VIL enantiomers with a favorable migration order (R-VIL followed by S-VIL). The optimized analytical conditions (75 mM acetate buffer, pH 4.5, containing 50 mM α-CD, 18 kV applied voltage, and 15 °C capillary temperature) provided a baseline separation of VIL enantiomers within 9 min. The developed method represents a cost-effective alternative to the enantiomeric impurity control of VIL. Symmetry is often a fundamental aspect of molecular structures and interactions, and our detailed analysis of the chiral recognition process contributes to the understanding of symmetry-related aspects in molecular systems. This developed method not only offers a cost-effective alternative for the enantiomeric impurity control of VIL but also provides valuable information regarding the mechanism of the chiral recognition process, aligning with the broader themes of symmetry in molecular sciences.

Cellulite, a multifactorial condition affecting approximately 98% of women, is characterised by dermal and subcutaneous architectural changes that compromise skin texture and elasticity. Its progression is closely linked to hormonal, vascular, and inflammatory factors, as well as ageing-related extracellular matrix degradation. This review critically evaluates bioactive compounds incorporated into topical and minimally invasive formulations for the management of cellulite and skin rejuvenation. A comprehensive literature search was conducted across major scientific databases and cosmetic ingredient repositories, focusing on active ingredients with demonstrated efficacy in enhancing skin structure. Key compounds include capsaicin, forskolin, L-carnitine, caffeine, retinol, and extracts from plants such as Centella asiatica, which act via lipolysis, improved circulation, and antioxidant effects. Minimally invasive agents, such as deoxycholic acid and poly-L-lactic acid, complement these strategies by inducing adipocytolysis and neocollagenesis, thereby improving skin firmness and contour. Evidence indicates that multi-active formulations combining lipolytic agents with antioxidants and collagen-stimulating molecules yield synergistic benefits, reducing adipose protrusion and improving skin firmness. However, heterogeneity in study design and the lack of standardised evaluation methods limit firm conclusions. Further studies should validate efficacy and optimise delivery. Integrated topical and injectable therapies represent a promising, multifunctional approach to addressing cellulite and age-related skin changes.